INCY
Price
$75.58
Change
-$2.15 (-2.77%)
Updated
Nov 15, 03:29 PM (EDT)
90 days until earnings call
UTHR
Price
$359.68
Change
-$26.59 (-6.88%)
Updated
Nov 15, 03:50 PM (EDT)
96 days until earnings call
Ad is loading...

INCY vs UTHR

Header iconINCY vs UTHR Comparison
Open Charts INCY vs UTHRBanner chart's image
Incyte
Price$75.58
Change-$2.15 (-2.77%)
Volume$1.37K
CapitalizationN/A
United Therapeutics
Price$359.68
Change-$26.59 (-6.88%)
Volume$884
CapitalizationN/A
INCY vs UTHR Comparison Chart
Loading...
INCY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
INCY vs. UTHR commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INCY is a Hold and UTHR is a StrongBuy.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (INCY: $77.73 vs. UTHR: $386.27)
Brand notoriety: INCY: Notable vs. UTHR: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INCY: 100% vs. UTHR: 70%
Market capitalization -- INCY: $14.97B vs. UTHR: $17.24B
INCY [@Biotechnology] is valued at $14.97B. UTHR’s [@Biotechnology] market capitalization is $17.24B. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INCY’s FA Score shows that 2 FA rating(s) are green whileUTHR’s FA Score has 2 green FA rating(s).

  • INCY’s FA Score: 2 green, 3 red.
  • UTHR’s FA Score: 2 green, 3 red.
According to our system of comparison, UTHR is a better buy in the long-term than INCY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INCY’s TA Score shows that 5 TA indicator(s) are bullish while UTHR’s TA Score has 5 bullish TA indicator(s).

  • INCY’s TA Score: 5 bullish, 4 bearish.
  • UTHR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both INCY and UTHR are a good buy in the short-term.

Price Growth

INCY (@Biotechnology) experienced а -5.60% price change this week, while UTHR (@Biotechnology) price change was -4.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.98%. For the same industry, the average monthly price growth was -3.24%, and the average quarterly price growth was +1.57%.

Reported Earning Dates

INCY is expected to report earnings on Feb 13, 2025.

UTHR is expected to report earnings on Feb 19, 2025.

Industries' Descriptions

@Biotechnology (-5.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UTHR($17.2B) has a higher market cap than INCY($15B). INCY has higher P/E ratio than UTHR: INCY (863.67) vs UTHR (16.97). UTHR YTD gains are higher at: 75.665 vs. INCY (23.794). UTHR has higher annual earnings (EBITDA): 1.55B vs. INCY (365M). UTHR has more cash in the bank: 3.33B vs. INCY (1.78B). INCY has less debt than UTHR: INCY (36.5M) vs UTHR (400M). INCY has higher revenues than UTHR: INCY (4.08B) vs UTHR (2.76B).
INCYUTHRINCY / UTHR
Capitalization15B17.2B87%
EBITDA365M1.55B23%
Gain YTD23.79475.66531%
P/E Ratio863.6716.975,089%
Revenue4.08B2.76B148%
Total Cash1.78B3.33B53%
Total Debt36.5M400M9%
FUNDAMENTALS RATINGS
INCY vs UTHR: Fundamental Ratings
INCY
UTHR
OUTLOOK RATING
1..100
2424
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
68
Overvalued
PROFIT vs RISK RATING
1..100
1003
SMR RATING
1..100
8850
PRICE GROWTH RATING
1..100
538
P/E GROWTH RATING
1..100
132
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

UTHR's Valuation (68) in the Pharmaceuticals Other industry is in the same range as INCY (97) in the Biotechnology industry. This means that UTHR’s stock grew similarly to INCY’s over the last 12 months.

UTHR's Profit vs Risk Rating (3) in the Pharmaceuticals Other industry is significantly better than the same rating for INCY (100) in the Biotechnology industry. This means that UTHR’s stock grew significantly faster than INCY’s over the last 12 months.

UTHR's SMR Rating (50) in the Pharmaceuticals Other industry is somewhat better than the same rating for INCY (88) in the Biotechnology industry. This means that UTHR’s stock grew somewhat faster than INCY’s over the last 12 months.

INCY's Price Growth Rating (5) in the Biotechnology industry is somewhat better than the same rating for UTHR (38) in the Pharmaceuticals Other industry. This means that INCY’s stock grew somewhat faster than UTHR’s over the last 12 months.

INCY's P/E Growth Rating (1) in the Biotechnology industry is in the same range as UTHR (32) in the Pharmaceuticals Other industry. This means that INCY’s stock grew similarly to UTHR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INCYUTHR
RSI
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
52%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
54%
Momentum
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
66%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 8 days ago
0%
Bullish Trend 8 days ago
0%
Declines
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
59%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
68%
Aroon
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
71%
View a ticker or compare two or three
Ad is loading...
INCY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

INCY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INCY has been loosely correlated with RPRX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if INCY jumps, then RPRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INCY
1D Price
Change %
INCY100%
-3.42%
RPRX - INCY
37%
Loosely correlated
-1.04%
UTHR - INCY
37%
Loosely correlated
-3.54%
INVA - INCY
36%
Loosely correlated
-4.28%
JAZZ - INCY
36%
Loosely correlated
-2.65%
SNDX - INCY
33%
Loosely correlated
+0.96%
More

UTHR and

Correlation & Price change

A.I.dvisor indicates that over the last year, UTHR has been loosely correlated with MNKD. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if UTHR jumps, then MNKD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTHR
1D Price
Change %
UTHR100%
-3.54%
MNKD - UTHR
37%
Loosely correlated
+0.86%
INCY - UTHR
36%
Loosely correlated
-3.42%
HALO - UTHR
27%
Poorly correlated
-7.93%
TNXP - UTHR
27%
Poorly correlated
-0.85%
ARGX - UTHR
27%
Poorly correlated
-0.72%
More